Literature DB >> 11812185

Spontaneous regression: a hidden treasure buried in time.

S A Hoption Cann1, J P van Netten, C van Netten, D W Glover.   

Abstract

Spontaneous tumor regression is a phenomenon that has been observed for hundreds, if not thousands of years. Although the term spontaneous implies 'without apparent cause', a review of case reports over the last several hundred years demonstrates that regression generally coincides with acute infections. Observations of this non-specific effect led to the emergence of active cancer immunotherapies by the 1700s. By the 1890s, William Coley refined this approach with a bacterial vaccine which, when administered properly, could induce complete regression of extensive metastatic disease. Unfortunately, after Coley's death, his vaccine and technique fell into obscurity. Modern approaches to treatment have reduced the occurrence of spontaneous regressions. Aseptic techniques and antibiotics significantly reduce postoperative infections, while chemotherapy and radiation impair immune activation even when an infection does occur. More than a century after its inception, Coley's vaccine and aggressive approach to treatment may still be one of most effective immunotherapies for cancer. Copyright 2002 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11812185     DOI: 10.1054/mehy.2001.1469

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  28 in total

Review 1.  Victory and defeat in the induction of a therapeutic response through vaccine therapy for human and canine brain tumors: a review of the state of the art.

Authors:  Michael R Olin; G Elizabeth Pluhar; Brian M Andersen; Rob Shaver; Nate N Waldron; Christopher L Moertel
Journal:  Crit Rev Immunol       Date:  2014       Impact factor: 2.214

2.  Therapeutic vaccines in renal cell carcinoma.

Authors:  Thomas Schwaab; Marc S Ernstoff
Journal:  Therapy       Date:  2011-07

Review 3.  The immune response in cancer: from immunology to pathology to immunotherapy.

Authors:  Nicolas A Giraldo; Etienne Becht; Yann Vano; Catherine Sautès-Fridman; Wolf H Fridman
Journal:  Virchows Arch       Date:  2015-06-16       Impact factor: 4.064

Review 4.  The Host Microbiome Regulates and Maintains Human Health: A Primer and Perspective for Non-Microbiologists.

Authors:  Sunil Thomas; Jacques Izard; Emily Walsh; Kristen Batich; Pakawat Chongsathidkiet; Gerard Clarke; David A Sela; Alexander J Muller; James M Mullin; Korin Albert; John P Gilligan; Katherine DiGuilio; Rima Dilbarova; Walker Alexander; George C Prendergast
Journal:  Cancer Res       Date:  2017-03-14       Impact factor: 12.701

Review 5.  Indoleamine 2,3-dioxygenase: is it an immune suppressor?

Authors:  Hatem Soliman; Melanie Mediavilla-Varela; Scott Antonia
Journal:  Cancer J       Date:  2010 Jul-Aug       Impact factor: 3.360

6.  Engaging Pattern Recognition Receptors in Solid Tumors to Generate Systemic Antitumor Immunity.

Authors:  Michael Brown
Journal:  Cancer Treat Res       Date:  2022

7.  Antitumor effects of a Toxoplasma mutant lacking lactate dehydrogenases.

Authors:  Yaqiong Li; Yue Zhang; Ningbo Xia; Taifang Zhou; Bang Shen
Journal:  Parasitol Res       Date:  2021-08-18       Impact factor: 2.289

8.  Dr William Coley and tumour regression: a place in history or in the future.

Authors:  S A Hoption Cann; J P van Netten; C van Netten
Journal:  Postgrad Med J       Date:  2003-12       Impact factor: 2.401

9.  Short-term spontaneous regression of myxofibrosarcoma in the scapular region.

Authors:  Akio Sakamoto; Eisuke Shiba; Masanori Hisaoka
Journal:  Skeletal Radiol       Date:  2014-06-10       Impact factor: 2.199

10.  Clinical uses of GM-CSF, a critical appraisal and update.

Authors:  Martha Arellano; Sagar Lonial
Journal:  Biologics       Date:  2008-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.